Enwei Pharmaceutical Co., Ltd. (SHE:301331)

China flag China · Delayed Price · Currency is CNY
36.54
+0.52 (1.44%)
At close: Aug 22, 2025, 2:57 PM CST
1.44%
Market Cap3.69B
Revenue (ttm)825.15M
Net Income (ttm)45.38M
Shares Out101.08M
EPS (ttm)0.45
PE Ratio80.92
Forward PEn/a
Dividend0.18 (0.49%)
Ex-Dividend DateMay 28, 2025
Volume1,594,126
Average Volume2,314,299
Open36.60
Previous Close36.02
Day's Range35.50 - 36.78
52-Week Range20.25 - 39.00
Beta0.75
RSI55.49
Earnings DateAug 26, 2025

About Enwei Pharmaceutical

Enwei Pharmaceutical Co., Ltd. develops and sells Chinese medicines in China. It offers drugs in the areas of gynecology, pediatrics, respiratory system, and other pharmaceutical fields. The company was founded in 2005 and is based in Chengdu, China. [Read more]

Sector Healthcare
Founded 2005
Employees 1,548
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301331
Full Company Profile

Financial Performance

In 2024, Enwei Pharmaceutical's revenue was 812.13 million, an increase of 3.43% compared to the previous year's 785.19 million. Earnings were 37.50 million, a decrease of -56.56%.

Financial Statements

News

There is no news available yet.